Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TA-7284 in Type 2 Diabetes Mellitus
NCT01387737Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- May 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of canagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Mitsubishi Tanabe Pharma. Started May 2011; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01387737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01387737.